| Autor: |
Carmen, Quirós, Antonio J, Amor, Ana M, de Hollanda, Gemma, Yago, Pilar, Ara, Ignacio, Conget |
| Rok vydání: |
2012 |
| Předmět: |
|
| Zdroj: |
Medicina clinica. 142(6) |
| ISSN: |
1578-8989 |
| Popis: |
The profile of the patient with type 2 diabetes mellitus (DM2) who requires insulin therapy is very diverse as are the results of this intervention and short/middle-term patient management. We evaluated the midterm results of an outpatient program starting insulin therapy with≥2 insulin injections/day in terms of metabolic control in different groups of patients.We analyzed prospectively 131 patients with DM2, without previous insulin treatment, who were prescribed treatment with≥2 insulin injections/day and who were enrolled in a specific ambulatory program in order to start insulin therapy in a Day Hospital for 6 months.The initial glycosylated hemoglobin (HbA1c) was 11.3 (2.3) % and decreased to 6.3 (1.4) % in 6 months, with HbA1c7% in 72.5% of them. The group of recently diagnosed patients (3 months, symptomatic severe hyperglycemia, D-group) were younger (57.1 [10.8] vs 64.2 [12.1] years; P.01) and had a higher starting HbA1c (12.1 [1.8] vs 10.5 [2.5] %; P.001) than patients included in the program for oral antidiabetic drugs' failure (F-group). At the end of the program 50% of D-group patients did not need insulin (6.3% on F-group [P.001]). There were no significant differences in either of 2 groups at study ends according to the final treatment scheme.Counselling patients with DM2 to start insulin with more than one injection per day in Day Hospital setting achieves and maintains a good metabolic control in the medium term in different patient profiles. Among symptomatic and recently diagnosed patients, insulin therapy can be stopped in 50% of them at the medium term. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
